CBP-8008

N/A

Report date: 2024/04/22 14:59:14
NMEFirst In Class

Base Information

Drug NameCBP-8008
Drug Alias NameCBP-8008
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionBromodomain and extra terminal domain protein degraders
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsProstatic Neoplasms, Castration-ResistantTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCoherent Biopharma Suzhou Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCoherent Biopharma Suzhou Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-ResistantTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A